Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lamon Kim D — Molecular Insight Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Lamon Kim D

Lamon Kim D

Director at Molecular Insight Pharmaceuticals, Inc. · on record since Feb 1, 2007

Insider trading activity of Lamon Kim D

Transactions on record: 1; since Apr 12, 2007

Open-market buys: 1; $42K

Open-market sells: 0

Companies traded: 1; last filing Apr 12, 2007

Figures computed from official regulatory filings — methodology.

Companies where Lamon Kim D has traded

Molecular Insight Pharmaceuticals, Inc.1 tx · $42K · Apr 12, 2007

Track record of Lamon Kim D

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lamon Kim D

Co-insiders of Lamon Kim D

Abdalian Charles H JrMolecular Insight Pharmaceuticals, Inc.
Attarian Mark AMolecular Insight Pharmaceuticals, Inc.
Babich John WMolecular Insight Pharmaceuticals, Inc.
Barlow David SMolecular Insight Pharmaceuticals, Inc.
Barrett John AMolecular Insight Pharmaceuticals, Inc.
Borys NicholasMolecular Insight Pharmaceuticals, Inc.
BRODY KENNETH DMolecular Insight Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BROSENS FRANKMolecular Insight Pharmaceuticals, Inc.

DONDERO JAMES DMolecular Insight Pharmaceuticals, Inc.

Epstein David RMolecular Insight Pharmaceuticals, Inc.

FEINBERG STEPHENMolecular Insight Pharmaceuticals, Inc.

FRANK DANIELMolecular Insight Pharmaceuticals, Inc.

Gallahue RobertMolecular Insight Pharmaceuticals, Inc.

Gottlieb ScottMolecular Insight Pharmaceuticals, Inc.

Greenstreet YvonneMolecular Insight Pharmaceuticals, Inc.

Hamermesh JoshuaMolecular Insight Pharmaceuticals, Inc.

HARLAN PRISCILLAMolecular Insight Pharmaceuticals, Inc.

HIGHLAND CAPITAL MANAGEMENT LPMolecular Insight Pharmaceuticals, Inc.

Kronauge James FMolecular Insight Pharmaceuticals, Inc.

LaFrance Norman D.Molecular Insight Pharmaceuticals, Inc.

LIMBER JOSEPH MMolecular Insight Pharmaceuticals, Inc.

Looney Paul AnthonyMolecular Insight Pharmaceuticals, Inc.

Martin Anthony FrancisMolecular Insight Pharmaceuticals, Inc.

McCray John EMolecular Insight Pharmaceuticals, Inc.

McDonnell Loan Opportunity Ltd.Molecular Insight Pharmaceuticals, Inc.

PETERS DANIELMolecular Insight Pharmaceuticals, Inc.

Pioneer Floating Rate TrustMolecular Insight Pharmaceuticals, Inc.

Quintessence Fund L.P.Molecular Insight Pharmaceuticals, Inc.

QVT Associates GP LLCMolecular Insight Pharmaceuticals, Inc.

QVT Fund LPMolecular Insight Pharmaceuticals, Inc.

STACK DAVID MMolecular Insight Pharmaceuticals, Inc.

STERLING LIONEL NMolecular Insight Pharmaceuticals, Inc.

Strand Advisors, Inc.Molecular Insight Pharmaceuticals, Inc.

Stylli HarryMolecular Insight Pharmaceuticals, Inc.

Taconic Associates LLCMolecular Insight Pharmaceuticals, Inc.

Taconic Capital Advisors LPMolecular Insight Pharmaceuticals, Inc.

Taconic Capital Advisors UK LLPMolecular Insight Pharmaceuticals, Inc.

Wachholz JamesMolecular Insight Pharmaceuticals, Inc.

Wallroth Donald E.Molecular Insight Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Molecular Insight Pharmaceuticals, Inc.	Apr 12, 2007	Buy	3,000	14.00	$42K	SEC